Seigo Kashii became the Corporate Auditor & Chair of the Board of Auditors in 2011 after serving as the Corporate Officer & Vice President of Legal Affairs Group at Astellas Pharma Inc. (formerly Fujisawa Pharmaceutical Co., Ltd.) and President &CEO of its US subsidiaries.
From 2014, as Corporate Officer and Head of Integrity & Compliance Division at Novartis Pharma K.K. and the Japan Country Head in Novartis, he was in charge of reconstructing and reinforcing the integrity and compliance structure in Japan. He became our company’s Corporate Auditor in 2017.